This report aims to provide a comprehensive presentation of the global market for Polycystic Kidney Disease Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polycystic Kidney Disease Treatment Drugs. This report contains market size and forecasts of Polycystic Kidney Disease Treatment Drugs in global, including the following market information:
Global Polycystic Kidney Disease Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Polycystic Kidney Disease Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
ANG-3070 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Polycystic Kidney Disease Treatment Drugs include Johnson & Johnson, Merck, Otsuka Holdings, Reata Pharmaceuticals and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Polycystic Kidney Disease Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polycystic Kidney Disease Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Polycystic Kidney Disease Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
ANG-3070
CIM-2
CR-8
Others
Global Polycystic Kidney Disease Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Polycystic Kidney Disease Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Global Polycystic Kidney Disease Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Polycystic Kidney Disease Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polycystic Kidney Disease Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Polycystic Kidney Disease Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Merck
Otsuka Holdings
Reata Pharmaceuticals
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Polycystic Kidney Disease Treatment Drugs, market overview.
Chapter 2: Global Polycystic Kidney Disease Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Polycystic Kidney Disease Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polycystic Kidney Disease Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Polycystic Kidney Disease Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polycystic Kidney Disease Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polycystic Kidney Disease Treatment Drugs Overall Market Size
2.1 Global Polycystic Kidney Disease Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Polycystic Kidney Disease Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Polycystic Kidney Disease Treatment Drugs Players in Global Market
3.2 Top Global Polycystic Kidney Disease Treatment Drugs Companies Ranked by Revenue
3.3 Global Polycystic Kidney Disease Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Polycystic Kidney Disease Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Polycystic Kidney Disease Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Polycystic Kidney Disease Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Polycystic Kidney Disease Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 ANG-3070
4.1.3 CIM-2
4.1.4 CR-8
4.1.5 Others
4.2 By Type - Global Polycystic Kidney Disease Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Polycystic Kidney Disease Treatment Drugs Revenue, 2024-2029
4.2.3 By Type - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Polycystic Kidney Disease Treatment Drugs Market Size, 2022 & 2029
5.1.2 Autosomal Dominant Polycystic Kidney Disease (ADPKD)
5.1.3 Autosomal Recessive Polycystic Kidney Disease (ARPKD)
5.2 By Application - Global Polycystic Kidney Disease Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Polycystic Kidney Disease Treatment Drugs Revenue, 2024-2029
5.2.3 By Application - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Polycystic Kidney Disease Treatment Drugs Market Size, 2022 & 2029
6.2 By Region - Global Polycystic Kidney Disease Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Polycystic Kidney Disease Treatment Drugs Revenue, 2024-2029
6.2.3 By Region - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2029
6.3.2 US Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.4.3 France Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2029
6.5.2 China Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.5.6 India Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Polycystic Kidney Disease Treatment Drugs Market Size, 2018-2029
7 Polycystic Kidney Disease Treatment Drugs Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Polycystic Kidney Disease Treatment Drugs Major Product Offerings
7.1.4 Johnson & Johnson Polycystic Kidney Disease Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Polycystic Kidney Disease Treatment Drugs Major Product Offerings
7.2.4 Merck Polycystic Kidney Disease Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Otsuka Holdings
7.3.1 Otsuka Holdings Company Summary
7.3.2 Otsuka Holdings Business Overview
7.3.3 Otsuka Holdings Polycystic Kidney Disease Treatment Drugs Major Product Offerings
7.3.4 Otsuka Holdings Polycystic Kidney Disease Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Otsuka Holdings Key News & Latest Developments
7.4 Reata Pharmaceuticals
7.4.1 Reata Pharmaceuticals Company Summary
7.4.2 Reata Pharmaceuticals Business Overview
7.4.3 Reata Pharmaceuticals Polycystic Kidney Disease Treatment Drugs Major Product Offerings
7.4.4 Reata Pharmaceuticals Polycystic Kidney Disease Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Reata Pharmaceuticals Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Polycystic Kidney Disease Treatment Drugs Major Product Offerings
7.5.4 Sanofi Polycystic Kidney Disease Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Polycystic Kidney Disease Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Polycystic Kidney Disease Treatment Drugs Market Drivers in Global Market
Table 3. Polycystic Kidney Disease Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Polycystic Kidney Disease Treatment Drugs in Global Market
Table 5. Top Polycystic Kidney Disease Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Polycystic Kidney Disease Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Polycystic Kidney Disease Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Polycystic Kidney Disease Treatment Drugs Product Type
Table 9. List of Global Tier 1 Polycystic Kidney Disease Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Polycystic Kidney Disease Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Polycystic Kidney Disease Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Polycystic Kidney Disease Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Polycystic Kidney Disease Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Polycystic Kidney Disease Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Polycystic Kidney Disease Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Polycystic Kidney Disease Treatment Drugs Product Offerings
Table 32. Johnson & Johnson Polycystic Kidney Disease Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Polycystic Kidney Disease Treatment Drugs Product Offerings
Table 36. Merck Polycystic Kidney Disease Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Otsuka Holdings Company Summary
Table 39. Otsuka Holdings Polycystic Kidney Disease Treatment Drugs Product Offerings
Table 40. Otsuka Holdings Polycystic Kidney Disease Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Otsuka Holdings Key News & Latest Developments
Table 42. Reata Pharmaceuticals Company Summary
Table 43. Reata Pharmaceuticals Polycystic Kidney Disease Treatment Drugs Product Offerings
Table 44. Reata Pharmaceuticals Polycystic Kidney Disease Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Reata Pharmaceuticals Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Polycystic Kidney Disease Treatment Drugs Product Offerings
Table 48. Sanofi Polycystic Kidney Disease Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Polycystic Kidney Disease Treatment Drugs Segment by Type in 2022
Figure 2. Polycystic Kidney Disease Treatment Drugs Segment by Application in 2022
Figure 3. Global Polycystic Kidney Disease Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Polycystic Kidney Disease Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Polycystic Kidney Disease Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Polycystic Kidney Disease Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Polycystic Kidney Disease Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Polycystic Kidney Disease Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Johnson & Johnson Polycystic Kidney Disease Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Polycystic Kidney Disease Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Otsuka Holdings Polycystic Kidney Disease Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Reata Pharmaceuticals Polycystic Kidney Disease Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Polycystic Kidney Disease Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
